2050
K. Smith et al.
PAPER
1H NMR (CDCl3): d = 8.08 (d, J = 8.5 Hz, 1 H, H6), 7.34 (d, J = 2.0
Hz, 1 H, H3), 7.14 (dd, J = 8.5, 2.0 Hz, 1 H, H5), 6.89 (s, exch., 1
H, NH), 3.06 [s, 6 H, N(CH3)2], 2.82 [septet, J = 7.0 Hz, 1 H,
CH(CH3)2], 1.21 [d, J = 7.0 Hz, 6 H, CH(CH3)2].
13C NMR (CDCl3): d = 155.1 (s, C=O), 144.5 (s, C4), 134.7 (s, C1),
129.6 (d, C3), 126.4 (d, C5), 121.1 (d, C6), 113.1 (s, C2), 36.4 [q,
N(CH3)2], 33.3 [d, CH(CH3)2], 23.9 [q, CH(CH3)2].
EI-MS: m/z (%) = 286 (M+81Br, 4), 284 (M+79Br, 4), 226 (6), 224
(6), 206 (20), 205 (100), 190 (6), 91 (15), 72 (80), 44 (16).
CI-MS: m/z (%) = 287 (MH+81Br, 50), 285 (MH+79Br, 51), 207
(100), 205 (28), 136 (8), 72 (95).
Bromine-lithium exchange was then effected by the addition of tert-
butyllithium in heptane (2.47 mL, 1.7 M, 4.2 mmol). The mixture
was stirred at 0 °C for 1 h then exposed to carbon monoxide, which
was introduced to the reaction vessel from a balloon fitted with a
needle, via a septum. The dilithio reagent thus obtained was stirred
under CO for 30 min, after which, the mixture was diluted with
EtOAc (10 mL) and then quenched with aq sat. NH4Cl solution (10
mL). The organic layer was separated, dried (MgSO4), and evapo-
rated under reduced pressure. The crude product obtained was puri-
fied by flash column chromatography on silica gel (hexane–Et2O,
1:1) to give the pure isatins 8–12. The yields obtained are recorded
in Table 3.
HRMS: m/z (M+) calcd for C12H1779BrN2O, 284.0466; found,
284.0468.
Isatin (8)
IR (KBr): 3210, 1710, 1610, 1450, 1310, 1200, 1120, 950, 780, 620
cm–1.
Anal. Calcd for C12H17BrN2O: C, 50.54; H, 6.01; N, 9.82. Found: C,
50.4; H, 5.8; N, 10.0.
1H NMR (DMSO-d6): d = 11.02 (s, exch., 1 H, NH), 7.58 (apparent
dt, J = 7.8, 1.3 Hz, 1 H, H6), 7.50 (dd, J = 7.8, 1.3 Hz, 1 H, H7),
7.06 (apparent dt, J = 7.8, 1.3 Hz, 1 H, H5), 6.91 (d, J = 7.8 Hz, 1
H, 4-H).
13C NMR (DMSO-d6): d = 184.4 (s, C3), 159.4 (s, C2), 150.7 (s,
C7a), 138.4 (d, C6), 124.7 (d, C4), 122.8 (d, C5), 117.8 (s, C3a),
112.2 (d, C7).
N¢-(2-Bromo-4-chlorophenyl)-N,N-dimethylurea (4d)
IR (KBr): 3290, 2985, 2495, 1690, 1575, 1520, 1480, 1415, 1370,
1290, 1245, 1185, 1050, 920, 855, 707, 662, 610 cm–1.
1H NMR (CDCl3): d = 8.20 (d, J = 8.0 Hz, 1 H, H6), 7.49 (d, J = 2.4
Hz, 1 H, H3), 7.25 (dd, J = 8.0, 2.4 Hz, 1 H, H5), 6.96 (s, exch., 1
H, NH), 3.07 [s, 6 H, N(CH3)2].
13C NMR (CDCl3): d = 154.7 (s, C=O), 135.9 (s, C1), 131.2 (d, C3),
128.3 (d, C5), 127.5 (s, C4), 121.4 (d, C6), 112.9 (s, C2), 36.4 [q,
N(CH3)2].
EI-MS: m/z (%) = 147 (M+, 22), 119 (84), 92 (100), 64 (47).
CI-MS: m/z (%) = 165 (M+ + NH4, 100), 148 (MH+, 13), 134 (43),
118 (50), 94 (22).
HRMS: m/z (M+) calcd for C8H5NO2, 147.0321; found, 147.0320.
EI-MS: m/z (%) = 280 (M+ 81Br37Cl, 2), 278 (M+81Br35Cl and
M+79Br37Cl, 6), 276 (M+79Br35Cl, 4), 233 (4), 231 (3), 199 (11), 197
(32), 72 (100), 44 (18).
Anal. Calcd for C8H5NO2: C, 65.31; H, 3.43; N, 9.52. Found: C,
65.2; H, 3.3; N, 9.7.
CI-MS: m/z (%) = 281 (MH+81Br37Cl, 12), 279 (MH+81Br35Cl and
M+79Br37Cl, 44), 277 (MH+79Br35Cl, 33), 201 (30), 199 (100), 197
(18), 165 (17), 72 (86).
HRMS: m/z (M+) calcd for C9H1079Br35ClN2O, 275.9665; found,
275.9668.
5-Methylisatin (9)
IR (KBr): 3322, 1750, 1622, 1527, 1433, 1226, 1151, 1150, 1044,
839, 752 cm–1.
1H NMR (DMSO-d6): d = 10.93 (s, exch., 1 H, NH), 7.37 (d, J = 8.0
Hz, 1 H, H6), 7.29 (s, 1 H, H4), 6.76 (d, J = 8.0 Hz, 1 H, H7), 2.24
(s, 3 H, CH3).
13C NMR (DMSO-d6): d = 184.6 (s, C3), 159.5 (s, C2), 148.5 (s,
C7a), 138.8 (d, C6), 132.0 (s, C5), 124.8 (d, C4), 117.8 (s, C3a),
112.0 (d, C7), 20.1 (q, CH3).
Anal. Calcd for C9H10 BrClN2O: C, 38.95; H, 3.63; N, 10.09.
Found: C, 38.8; H, 3.8; N, 10.3.
N¢-(2-Bromo-4-fluorophenyl)-N,N-dimethylurea (4e)
IR (KBr): 3280, 2970, 1670, 1580, 1520, 1480, 1420, 1375, 1290,
1250, 1185, 1050, 1020, 915, 860, 705, 660, 610 cm–1.
EI-MS: m/z (%) = 161 (M+, 21), 133 (21), 104 (41), 78 (43), 51 (72),
1H NMR (CDCl3): d = 8.16 (dd, J = 9.2, 5.9 Hz, 1 H, H6), 7.25 (dd,
J = 7.9, 2.9 Hz, 1 H, H3), 7.03 (ddd, J = 9.2, 8.0, 2.9 Hz, 1 H, H5),
6.84 (s, exch., 1 H, NH), 3.07 [s, 6 H, N(CH3)2].
43 (100).
CI-MS: m/z (%) = 179 (M+ + NH4, 100), 162 (MH+, 10), 150 (20),
148 (33), 132 (30), 108 (15).
13C NMR (CDCl3): d = 158.80, 156.36 (C4), 155.0 (s, C=O),
133.58, 133.55 (C1), 122.14, 122.06 (C6), 118.90, 118.64 (C3),
115.23, 115.01 (C5), 112.93, 112.83 (C2), 36.4 [q, N(CH3)2].
HRMS: m/z (M+) calcd for C9H7NO2, 161.0478; found, 161.0477.
Anal. Calcd for C9H7NO2: C, 67.07; H, 4.38; N, 8.69. Found: C,
67.2; H, 4.5; N, 8.6.
EI-MS: m/z (%) = 262 (M+81Br, 9), 260 (M+79Br, 9), 181 (78), 109
(18), 108 (18), 82 (14), 72 (100), 56 (19), 44 (22).
5-iso-Propylisatin (10)
CI-MS: m/z (%) = 280 (M+81Br + NH4, 9), 278 (M+79Br + NH4, 9),
263 (MH+81Br, 100), 261 (MH+79Br, 94), 183 (8), 181 (9), 72 (85),
44 (22).
HRMS: m/z (M+) calcd for C9H1079BrFN2O, 259.9961; found,
259.9960.
IR (KBr): 3351, 1752, 1620, 1522, 1431, 1149, 1046, 1041, 848,
770, 706 cm–1.
1H NMR (DMSO-d6): d = 10.95 (s, exch., 1 H, NH), 7.47 (dd,
J = 8.0, 1.4 Hz, 1 H, H6), 7.37 (d, J = 1.4 Hz, 1 H, H4), 6.83 (d,
J = 8.0 Hz, 1 H, H7), 2.86 [septet, J = 6.9 Hz, 1 H, CH(CH3)2], 1.16
[d, J = 6.9 Hz, 6 H, CH(CH3)2].
13C NMR (DMSO-d6): d = 184.6 (s, C3), 159.6 (s, C2), 148.9 (s,
C7a), 143.2 (d, C6), 136.6 (s, C5), 122.3 (d, C4), 117.8 (s, C3a),
112.1 (d, C7), 32.7 [d, CH(CH3)2], 23.7 [q, CH(CH3)2].
Anal. Calcd for C9H10BrFN2O: C, 41.40; H, 3.86; N, 10.73. Found:
C, 41.6; H, 3.9; N, 10.6.
Formation of Isatins 8–12 from N¢-(2-Bromoaryl)-N,N-dimeth-
ylureas 4; Typical Procedure
EI-MS: m/z (%) = 189 (M+, 25), 161 (53), 146 (100), 91 (76), 63
To a cooled solution (0 °C) of the appropriate N¢-(2-bromoaryl)-
N,N-dimethylurea 4 (2.0 mmol) in anhydrous THF (15 mL) under a
nitrogen atmosphere was added a solution of methyllithum in Et2O
(2.1 mL, 1.0 M, 2.1 mmol), in order to deprotonate the nitrogen.
(50), 41 (53), 39 (78).
CI-MS: m/z (%) = 207 (M+ + NH4, 100), 190 (MH+, 8), 176 (37),
160 (57), 136 (17), 77 (12).
Synthesis 2003, No. 13, 2047–2052 © Thieme Stuttgart · New York